Results 121 to 130 of about 17,376 (176)

Canadian Society of Nephrology Commentary on the 2025 Kidney Disease Improving Global Outcomes Clinical Practice Guidelines for Autosomal Dominant Polycystic Kidney Disease. [PDF]

Can J Kidney Health Dis
Lanktree MB, Ashawasega N, Bevilacqua M, Bichet DG, Bollée G, Brown PA, Girard L, Goodyer P, Hingwala J, Lemaire M, McFarlane P, Moist L, Pei Y, Proulx N, Schott C, Soroka S, Vlasschaert C, Watkins N, Alam A.   +18 more
europepmc   +1 more source

Natural history of simple and complex cysts in autosomal dominant polycystic kidney disease on MRI. [PDF]

Commun Med (Lond)
Hu Z, Li C, Blumenfeld JD, Prince MR.
europepmc   +1 more source

Post-COVID-19 Outcomes of Patients with Autosomal Dominant Polycystic Kidney Disease: A Multicenter Controlled Study. [PDF]

J Clin Med
Karadag S, Ozturk S, Aktas N, Trabulus S, Aydin Z, Dheir H, Kuzu T, Yilmaz F, Ayar Y, Pembegul I, Basturk T, Mutluay R, Cebeci E, Ergul M, Akcali E, Ozler TE, Azak A, Islam M, Arici M, Ates K.   +19 more
europepmc   +1 more source

Octreotide long-acting release in the treatment of autosomal dominant polycystic kidney disease: a meta-analysis. [PDF]

Front Endocrinol (Lausanne)
Jin M, Shi P, Yu Y.
europepmc   +1 more source

Vascular transcriptional and metabolic changes precede progressive intrarenal microvascular rarefaction in autosomal dominant polycystic kidney disease. [PDF]

Am J Physiol Renal Physiol
Yilmaz G, Singha SK, Savaliya B, Abdelfattah A, Elsekaily W, Xu X, Zhang Y, Hanna C, Hogan MC, Chade AR, Eirin A, Irazabal MV.   +11 more
europepmc   +1 more source

Recurrent obturator hernia in a patient with autosomal dominant polycystic kidney disease undergoing peritoneal dialysis: a case report. [PDF]

CEN Case Rep
Okumura K, Kawanishi T, Abe Y, Tanami H, Sugano N.   +4 more
europepmc   +1 more source

Validation of Combining Total Kidney Volume and Kidney Failure Risk Equation in Autosomal Dominant Polycystic Kidney Disease. [PDF]

Kidney Int Rep
Bevilacqua M, Guan M, Romann A, Er L, Shao T, Farah M, Elliott MD.   +6 more
europepmc   +1 more source

Abnormal purinergic signaling contributes to development of renal cysts in autosomal dominant polycystic kidney disease. [PDF]

Purinergic Signal
Ivanov V, Wu A, Crocetti L, Meng Z, Shrestha-Maskey P, Liao TD, Adrianto I, Guerrini G, Ortiz PA, Pavlov TS.   +9 more
europepmc   +1 more source

Kidney stones and autosomal dominant polycystic kidney disease: a state-of-the-art review. [PDF]

Ren Fail
Borghol AH, Azooz M, Bou Antoun MT, Souvalian L, Shami B, Mina J, Munairdjy Debeh FG, Ghanem A, Sandouk H, Rangarajan V, Hanna D, Naranjo CD, Drexler Y, Norouzi S, Noruzi A, Salih M, Klett DE, Porter IE, Dahl NK, Chebib FT.   +19 more
europepmc   +1 more source